Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Mapping the Biochemical Scale of Residue-Level Epistasis in Porphyria-Associated Genes

EF 2025-26

Résumé
Despite their high abundance, it's often unclear whether and under what circumstances a genetic variant causes disease. Although recent technologies enable large-scale functional assays of variants in disease-associated genes, these approaches rarely consider the influence of additional inherited variants that may modify the pathogenicity of a primary mutation. My proposed research will investigate how genetic context shapes variant interpretation using heme biosynthesis as a model pathway. In doing so, my research will help explain why two individuals with the same variant may have different clinical outcomes. Clinically, deficiency in heme biosynthesis manifests as porphyria, yet only ~10% of individuals with variants in heme-related genes develop the disease. Classical genetics have shown that heme metabolism is tightly integrated with iron regulation, oxidative stress response, and DNA damage repair. I hypothesize that secondary variants within these pathways may modulate the pathogenicity of heme variants. I will quantify genetic interactions at three scales: within the same heme gene, between different heme genes, and between heme genes and interacting pathways. To accomplish this, I will comprehensively mutagenize targeted regions of each gene and measure non-linear effects on cell growth in conditions requiring both genes to function. I will then compare functional scores in the presence and absence of secondary variants to identify residues and loci sensitive to genetic context. This research will generate functional evidence for how secondary variants modify potentially pathogenic mutations and at what biochemical scale, improving holistic variant interpretation and strengthening predicative frameworks for explaining complex genetic diseases.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572787
Name
McDonald Molly K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mapping the Biochemical Scale of Residue-Level Epistasis in Porphyria-Associated Genes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Clinical Variation Interpretation; Deep Mutational-Scanning; Epistasis; Genetic-Context; Genotype-Phenotype; Heme Metabolism; Humanized Yeast Models; Incomplete Penetrance; Porphyria; Variant Effect Mapping
Abstract
Despite their high abundance, it's often unclear whether and under what circumstances a genetic variant causes disease. Although recent technologies enable large-scale functional assays of variants in disease-associated genes, these approaches rarely consider the influence of additional inherited variants that may modify the pathogenicity of a primary mutation. My proposed research will investigate how genetic context shapes variant interpretation using heme biosynthesis as a model pathway. In doing so, my research will help explain why two individuals with the same variant may have different clinical outcomes. Clinically, deficiency in heme biosynthesis manifests as porphyria, yet only ~10% of individuals with variants in heme-related genes develop the disease. Classical genetics have shown that heme metabolism is tightly integrated with iron regulation, oxidative stress response, and DNA damage repair. I hypothesize that secondary variants within these pathways may modulate the pathogenicity of heme variants. I will quantify genetic interactions at three scales: within the same heme gene, between different heme genes, and between heme genes and interacting pathways. To accomplish this, I will comprehensively mutagenize targeted regions of each gene and measure non-linear effects on cell growth in conditions requiring both genes to function. I will then compare functional scores in the presence and absence of secondary variants to identify residues and loci sensitive to genetic context. This research will generate functional evidence for how secondary variants modify potentially pathogenic mutations and at what biochemical scale, improving holistic variant interpretation and strengthening predicative frameworks for explaining complex genetic diseases.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
McDonald, Molly K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~